检索结果 - Ofrat Beyar‐Katz
- Showing 1 - 7 results of 7
-
1
-
2
Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy 由 Ofrat Beyar‐Katz, Etty Kruzel Davila, Tsila Zuckerman, Riva Fineman, Nuhad Haddad, Doaa Okasha, Israel Henig, Ronit Leiba, Jacob M. Rowe, Yishai Ofran
出版 2015Revisão -
3
-
4
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies 由 Dan Cohen, Efrat Luttwak, Ofrat Beyar‐Katz, Shir Hazut Krauthammer, Yael Bar‐On, Odelia Amit, Ronit Gold, Chava Perry, Irit Avivi, Ron Ram, Einat Even‐Sapir
出版 2021Artigo -
5
-
6
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma 由 Chava Perry, Efrat Luttwak, R. Balaban, Gabi Shefer, M. Morales, A. Aharon, Yaara Tabib, Yaël Cohen, Noam Benyamini, Ofrat Beyar‐Katz, Miriam Neaman, Roy Vitkon, Noa Keren‐Khadmy, M Levin, Y. Herishanu, Irit Avivi
出版 2021Artigo -
7
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study 由 Ron Ram, David Hagin, Nino Kikozashvilli, Tal Freund, Odelia Amit, Yael Bar‐On, Ofrat Beyar‐Katz, Gabi Shefer, M. Morales, Chen Karni, Ronit Gold, Sigi Kay, Chen Glait‐Santar, Rinat Eshel, Chava Perry, Irit Avivi, Arie Apel, Noam Benyamini, David Shasha, Ronen Ben‐Ami
出版 2021Artigo
相关主题
Internal medicine
Medicine
Biology
Immunology
Adverse effect
Cancer
Cancer research
Chemotherapy
Disease
Lymphoma
Multivariate analysis
Univariate analysis
2019-20 coronavirus outbreak
Antibiotics
Biotechnology
CD19
CD8
Cancer stem cell
Capecitabine
Cart
Clinical trial
Colorectal cancer
Concomitant
Confidence interval
Coronavirus disease 2019 (COVID-19)
ELISPOT
Engineering
Febrile neutropenia
Focal segmental glomerulosclerosis
Gastroenterology